news + events
08.08.2024
Heranova™ Launches Early Access Program for HerResolve™, a Potential First FDA-Cleared, Non-Invasive Endometriosis Test
06.18.2024
Heranova Appoints Dr. Marcel van Duin as Chief Scientific Officer
03.28.2024
Heranova Lifesciences Debuts with $13.5 Million Seed and Seed+ Round Funding to Offer Integrated Clinical Solutions to Women’s Health